Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Ernexa Therapeutics Inc. (ERNA) had Return on Investments of -34.73% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.24M |
|
-- |
|
-- |
|
$1.99M |
|
$-1.99M |
|
$0.76M |
|
$-1.23M |
|
$-1.23M |
|
$-1.24M |
|
$-1.24M |
|
$-1.24M |
|
$-1.24M |
|
$-1.99M |
|
$-1.92M |
|
8.23M |
|
8.23M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$3.38M |
|
$0.09M |
|
$2.79M |
|
$6.17M |
|
$2.14M |
|
-- |
|
$0.46M |
|
$2.60M |
|
$3.57M |
|
$1.53M |
|
$3.57M |
|
7.85M |
|
| Cash Flow Statement Financials | |
$-5.87M |
|
$-0.02M |
|
$7.21M |
|
$1.73M |
|
$3.05M |
|
$1.32M |
|
$1.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.89M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-34.74% |
|
-81.26% |
|
-20.09% |
|
|
Return on Investments |
-34.73% |
$0.45 |
|
$-0.72 |
|
$-0.71 |
|